Results 61 to 70 of about 1,970 (174)

Receiver operating characteristic (ROC) curve analyses.

open access: yes, 2016
The ROC plots for CEA (A), CA153 (B), CA125 (C) and the combination of CEA and CA153 (D) were used to differentiate breast cancer from benign disease. AUC, area under the receiver operating characteristic curve; CI, confidence interval.
Yu Mei (847605)   +4 more
core   +1 more source

Effect of bioactive whey protein-supplemented paclitaxel on nutritional status and tumor growth in a mouse model of subcutaneously transplanted triple-negative breast cancer

open access: yes, 2022
Purpose: To study the effect of bioactive whey protein-supplemented paclitaxel on nutritional status and tumor growth in a mouse model of subcutaneously transplanted triple negative breast cancer (TNBC).Methods: Eighty (80) mice were equally assigned to ...
Chen, Xi, Zhang, Min
core   +1 more source

Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy

open access: yesCancer Medicine, 2022
To reveal the correlation of dynamic serum tumor markers (STMs) and molecular features of epidermal growth factor receptor‐mutated (EGFR‐mutated) lung cancer during targeted therapy, we retrospectively reviewed 303 lung cancer patients who underwent ...
Zhuxing Chen   +17 more
doaj   +1 more source

A Case Report of Aggressive Angiomyxoma in the Buttock of a Female

open access: yesClinical Case Reports, Volume 13, Issue 9, September 2025.
ABSTRACT Aggressive angiomyxoma presents distinctive MRI features like “whirl sign” and “layering sign.” Laparoscopic combined with perianal incision can minimize bleeding and organ damage risks for pelvic‐extending tumors. Surgical excision with negative pressure drainage aids wound healing. Long‐term follow‐up is crucial to prevent recurrence.
Aiwen Le, Zhibin Zheng, Tong Wu
wiley   +1 more source

Natural Agents Modulating Ferroptosis in Cancer: Molecular Pathways and Therapeutic Perspectives

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 17, September 2025.
ABSTRACT Ferroptosis, a controlled cell death influenced by iron‐dependent lipid peroxidation, presents potential therapeutic targets for cancer treatment due to its unique molecular pathways and potential drug resistance. Natural compounds, such as polyphenols, flavonoids, terpenoids and alkaloids, can influence ferroptosis via important signalling ...
Md. Al Amin   +12 more
wiley   +1 more source

Low Cholinesterase Is a Potential Poor Prognostic Factor in Colorectal Cancer Presenting With Tumor Markers Negative

open access: yesCancer Reports, Volume 8, Issue 8, August 2025.
ABSTRACT Background Colorectal cancer (CRC) is the third most common malignant tumor in the world and has the second highest mortality rate. Tumor markers are proteins used to diagnose and monitor cancer. Serum cholinesterase (CHE) is a nutritional indicator indicating the liver''s ability to synthesize proteins and is a predictor of CRC ...
Tawfik Ali Hamood Alburiahi   +6 more
wiley   +1 more source

CA153等在乳腺癌肺癌及几种疾病中的应用

open access: yesZhongguo shiyan zhenduanxue, 2007
目的探讨血清以及胸水中CA153在乳腺癌及肺部疾病中的临床应用价值。方法采用微粒子酶免疫化学发光分析法对16例乳腺癌患者血清、27例肺癌患者的血清以及其中8例肺癌患者的胸水、122例肺部良性疾病患者的血清及113例正常健康体检者的血清进行CA153、CEA、CA199、CA125水平测定。结果乳腺癌患者血清CA153水平(37.06±75.03 U/ml)为各种疾病中最高;肺癌组4项肿瘤标志物的水平显著高于正常对照组与肺部良性疾病组 ...
胡望平   +8 more
doaj  

Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer

open access: yesCancer Medicine, Volume 14, Issue 11, June 2025.
The figure outlines the process of tumor cell migration, the samples available for testing and the classification of enrichment assays, and the use of circulating cells. CSF: cerebrospinal fluid‐derived circulating tumor cell, CTC: circulating tumor cell, CTEC: circulating tumor endothelial cell, DTC: disseminated tumor cell, MRD: minimal residual ...
Saiying Ma   +3 more
wiley   +1 more source

Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer

open access: yes, 2017
The risk factors for predicting bone metastases in patients with breast cancer are still controversial. Here, a total of 2133 patients with breast cancer, including 327 with bone metastases (15.33%) and 1806 without bone metastases (84.67%) were ...
Jia-Ming Liu   +5 more
core   +1 more source

An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti‐Angiogenic Agents for Therapy: A Case Report

open access: yesCancer Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background Although the presence of Kirsten murine sarcoma virus (KRAS) mutations predicts a failure of non‐small cell carcinoma (NSCLC) patients to benefit from epidermal growth factor receptor (EGFR)—tyrosine kinase inhibitor (TKI) therapy it may be more sensitive to programmed combination therapy of programmed death 1 (PD‐1)/programmed ...
Li Wang   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy